DEPASQUALE MICHAEL W 4

What Happened Michael W. DePasquale, CEO of BIO-key International, received 250 shares on June 30, 2026. The shares were issued at an acquisition price of $3.83 per share, for a total value of $958. This was an award/acquisition under the company’s employee purchase plan, not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-06-30, 250 shares at $3.83 each (total $958).
• Transaction type: A — grant/award or other acquisition under the BIO-key 2021 Employee Stock Purchase Plan (ESPP), as amended.
• Ownership after transaction: Not disclosed in this Form 4.
• Footnotes: The shares were acquired under the company’s 2021 ESPP and the transaction was reported as exempt under Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key’s 1-for-10 reverse stock split effective April 30, 2026.
• Filing timeliness: Report filed 2026-07-02 for a 2026-06-30 transaction — filed within the typical two-business-day Form 4 window.

Context This was an internal plan acquisition (ESPP) rather than a market buy or sale. Such awards are common for employees and executives and are often exempt from short-swing profit liability under Rule 16b-3 when made under an approved plan. The dollar value here is small ($958) after the recent 1-for-10 reverse split, so this item is informational rather than a strong market signal.